Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14433714 | 0.88 | POLB (0.75) | POLBALDH1A1TSHRLMNAGAA | |
| SCHEMBL14493662 | 0.88 | POLB (0.75) | POLBALDH1A1TSHRLMNAGAA | |
| SCHEMBL29838840 | 0.88 | POLB (0.75) | POLBALDH1A1TSHRLMNAGAA | |
| SCHEMBL1058665 | 0.88 | POLB (0.75) | POLBALDH1A1TSHRLMNAGAA | |
| SCHEMBL13589979 | 0.88 | POLB (0.75) | POLBALDH1A1TSHRLMNAGAA | |
| SCHEMBL17818866 | 0.83 | POLB (0.50) | POLBALDH1A1TSHRGAATHRB | |
| SCHEMBL6865696 | 0.82 | POLB (0.68) | POLBALDH1A1TSHRLMNAGAA | |
| SCHEMBL1089318 | 0.82 | POLB (0.46) | POLBALDH1A1TSHRLMNAGAA | |
| SCHEMBL23406969 | 0.79 | POLB (0.64) | POLBALDH1A1TSHRLMNAGAA | |
| SCHEMBL503339 | 0.79 | POLB (0.64) | POLBALDH1A1TSHRLMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010965-A | Photochromic spiropyran derivative containing adamantyl group and preparation method and application thereof | 安徽师范大学 | 2026-05-12 | — | — | CN | claimed |
| CN-117467249-A | Anti-irradiation fruit fresh-keeping film and preparation method thereof | 台州鸿博辐照科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-117070138-A | Quick-drying alkyd resin paint and preparation method thereof | 山东齐鲁漆业有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-116410092-A | Idebenone derivative, preparation method and application thereof | 山东大学齐鲁医院(青岛) | 2023-07-11 | — | — | CN | claimed |
| CN-122010965-A | Photochromic spiropyran derivative containing adamantyl group and preparation method and application thereof | 安徽师范大学 | 2026-05-12 | — | — | CN | disclosed |
| CN-119036431-A | Ion driver containing ion channel interface and preparation method thereof | 苏州大学 | 2024-11-29 | — | — | CN | disclosed |
| CN-117467249-A | Anti-irradiation fruit fresh-keeping film and preparation method thereof | 台州鸿博辐照科技有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-117070138-A | Quick-drying alkyd resin paint and preparation method thereof | 山东齐鲁漆业有限公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-116410092-A | Idebenone derivative, preparation method and application thereof | 山东大学齐鲁医院(青岛) | 2023-07-11 | — | — | CN | disclosed |
| CN-112384489-A | Method for producing organic compound | 尤尼吉可株式会社 | 2021-02-19 | — | — | CN | disclosed |
| CN-109694417-B | Simple and efficient purification and recovery method of pipeline crystalline alpha-and gamma-cyclodextrin crystals | 北京理工大学 | 2021-01-08 | — | — | CN | disclosed |
| WO-2020009016-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND | ユニチカ株式会社 | 2020-01-09 | — | — | WO | disclosed |
| WO-2011066168-A1 | POTASSIUM CHANNEL MODULATORS | ABBOTT LABORATORIES (US) | 2011-06-03 | — | — | WO | disclosed |
| US-20110124642-A1 | POTASSIUM CHANNEL MODULATORS | ABBOTT LABORATORIES (US) | 2011-05-26 | — | — | US | disclosed |
| US-20100291642-A1 | Process For Preparing Dipeptidyl Peptidase IV Inhibitors And Intermediates Therefor | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-11-18 | — | — | US | disclosed |
| US-7741082-B2 | Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-06-22 | — | — | US | disclosed |
| US-20050260712-A1 | Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor | ASTRAZENECA AB (SE) | 2005-11-24 | — | — | US | disclosed |
| US-6348625-B1 | TREATING CORRESPONDING CARBOXYLIC ACID FUNCTIONAL GROUP WITH N,N-DIETHYL-1,1,2,3,3,3-HEXAFLUOROPROPYLAMINE FOLLOWED BY AMMONIA | ANDERSON GLORIA LONG (US) | 2002-02-19 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050260712-A1 | Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor | DNPEP, DPP4, PEPD | POLB 1051/4885ALDH1A1 377/4885TSHR 2534/4885 |
| US-20110124642-A1 | POTASSIUM CHANNEL MODULATORS | KCNQ1, KCNQ2, KCNQ3 | POLB 4381/4885ALDH1A1 1644/4885TSHR 1471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.